Cow's Milk Allergy Clinical Trial
— HYPO STORYOfficial title:
Study to Assess Hypoallergenicity of a Hydrolysed Protein Formula in Children With Confirmed Cow's Milk Allergy
Verified date | April 2024 |
Source | Nutricia Research |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Study to demonstrate hypoallergenicity of a hydrolysed protein infant formula in a population of children with confirmed cow's milk allergy.
Status | Suspended |
Enrollment | 29 |
Est. completion date | March 31, 2027 |
Est. primary completion date | December 31, 2026 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 0 Days to 3 Years |
Eligibility | Inclusion Criteria: 1. Infants and children aged up to 3 years. 2. Diagnosed with cow's milk allergy (or re-confirmed), within two months prior to the study (challenge day #1), by: 1. Physician-supervised double-blind oral food challenge; or 2. Physician-supervised open oral food challenge that elicited objective immediate allergic reactions; or 3. Report of convincing allergic reaction to cow's milk or a milk-containing food product, in conjunction with presence of milk-specific serum Immunoglobuline E (IgE) level > 0.7 kilounit per liter (U/L) or by skin prick test (wheal size = 3mm). 3. Willing to switch to a different hypoallergenic formula 4. On elimination diet (commercially available, hypoallergenic infant formula ) and free of clinical symptoms, or with controlled stable symptoms, for at least one week preceding the study (challenge day #1). 5. Expected minimal consumption of 144ml of test product/day during the open challenge. 6. Written informed consent provided by parents/guardians, according to local law. Exclusion Criteria: 1. Infants/children who are more suitable to use AAF as first-line formula, including but not limited to those with high risk of anaphylaxis (prior history of anaphylaxis and currently not using eHF) or severe forms of non-IgE-mediated CMA such as eosinophilic oesophagitis, enteropathies, or Food Protein-Induced Enterocolitis Syndrome (FPIES). 2. Diagnosis or known allergy to any of the ingredients in the test product. 3. Congenital anomalies which will interfere with oral feeding or gastrointestinal tract, other chronic diseases (including but not limited to cardiovascular disease, malignancy, hepatic disease, renal disease, haematological disease, neurological disease, immunological and endocrine disease), major gastrointestinal disease/abnormalities, or any other medical condition that could interfere with the identification of allergic reactions. 4. (Twin / triplet) sibling of an infant/child already participating in the study. 5. Investigator's uncertainty about the willingness or ability of the subject and his/her parents to comply with the protocol requirements. 6. Participation in any other studies involving investigational or marketed products concomitantly or within two weeks prior to entry into the study. 7. Employees and/or children/family members or relatives of employees of Nutricia Research or the participating study sites. |
Country | Name | City | State |
---|---|---|---|
Italy | Pediatric hospital Bambino Gesù | Rome |
Lead Sponsor | Collaborator |
---|---|
Nutricia Research |
Italy,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Relevant parameters routinely collected in the clinic | e.g serum IgE results | 25-35 days | |
Other | Incidence, seriousness, severity and relatedness of Adverse Events | Safety and tolerance parameters | 25-35 days | |
Other | Demographics characteristics | Demographics characteristics | at baseline | |
Other | Relevant parameters routinely collected in the clinic | e.g. skin prick test results | 25-35 days | |
Other | Birth length | cm | at baseline | |
Other | Birth weight | g | at baseline | |
Other | anthropometrics | e.g. weight and lenght | at baseline | |
Primary | Hypoallergenicity | The percentage of children tolerating the formula tested by double-blind, placebo-controlled food challenge and a subsequent open challenge. | 25-35 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02738060 -
The Effect of Baked Milk on Cow's Milk Allergy
|
Phase 2 | |
Recruiting |
NCT02149134 -
Evaluation of the Efficacy of a New Infant Formula in Subjects With Cow's Milk Allergy
|
Phase 2 | |
Recruiting |
NCT01891916 -
Effect Of Lactobacillus GG on Atopic March
|
N/A | |
Completed |
NCT01622426 -
Tolerance to a New Free Amino Acid-based Formula in Children With IgE or Non-IgE-mediated Cow's Milk Allergy
|
N/A | |
Completed |
NCT01634490 -
Effects of Different Dietary Regimens on Tolerance Acquisition in Children With Cow's Milk Allergy
|
N/A | |
Completed |
NCT02466035 -
Epigenetic Effects Involved in Children With Cow's Milk Allergy (EPICMA)
|
N/A | |
Completed |
NCT02379598 -
Effect of Therapy With Aminoacid Based Formula Versus Hydrolyzed Whey Proteins in Children With Cow's Milk Allergy
|
N/A | |
Completed |
NCT04330092 -
Diagnosis of Cow's Milk Protein Allergy
|
||
Not yet recruiting |
NCT02081651 -
Parmigiano-Reggiano Cheese as a Possible Strategy to Acquire Oral Tolerance in Children With Cow's Milk Allergy
|
Phase 3 | |
Completed |
NCT03462030 -
Baked Milk Oral Immunotherapy for Cow's Milk Allergy
|
Phase 2 | |
Completed |
NCT02465905 -
Oral Immunotherapy in Cow's Milk Allergy (CMA) in Children : "Petit Lait" Study
|
N/A | |
Not yet recruiting |
NCT06456541 -
Infant Formula in Infants and Children With Cow's Milk Allergy
|
N/A | |
Recruiting |
NCT02062476 -
Epigenetic Effects Elicited By Lactobacillus GG In Children With Cow's Milk Allergy
|
Phase 2 | |
Completed |
NCT01589731 -
Polymerized Beta-lactoglobulin Comparative Immunoreactivity
|
N/A | |
Terminated |
NCT02405923 -
Growth, Safety and Tolerance of a Rice Protein Hydrolysate Formula in Infants With Cow's Milk Protein Allergy
|
N/A | |
Terminated |
NCT04910373 -
Extensively Hydrolyzed Infant Formula in Infants and Children With Cow's Milk Allergy
|
N/A | |
Recruiting |
NCT01968278 -
Use of Baked Milk in Oral Immunotherapy for Severe IgE-mediated Cow's Milk Protein Allergic Patients
|
N/A | |
Withdrawn |
NCT01470768 -
Evaluation of Fatty Acid Levels and Growth in Infants Fed Amino Acid Based (AA) Formulas
|
N/A | |
Recruiting |
NCT05883384 -
Validity of Cow's Milk-related Symptom Score Among Children Suspected to Have Cow's Milk Protein Alergy
|
||
Completed |
NCT01901380 -
Cow's Milk Allergy and Functional Gastrointestinal Disorders
|
N/A |